The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Role of Transforming Growth Factor Beta in Human Cancer
Abstract
Transforming growth factor beta (TGF-β) is a ubiquitous and essential regulator of cellular and physiologic processes including proliferation, differentiation, migration, cell survival, angiogenesis, and immunosurveillance. Alterations in the TGF-β signaling pathway, including mutation or deletion of members of the signaling pathway and resistance to TGF-β-mediated inhibition of proliferation are frequently observed in human cancers. Although these alterations define a tumor suppressor role for the TGF-β pathway in human cancer, TGF-β also mediates tumor-promoting effects, either through differential effects on tumor and stromal cells or through a fundamental alteration in the TGF-β responsiveness of the tumor cells themselves. TGF-β and members of the TGF-β signaling pathway are being evaluated as prognostic or predictive markers for cancer patients. Ongoing advances in understanding the TGF-β signaling pathway will enable targeting of this pathway for the chemoprevention and treatment of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Self-citationDPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon, M., Derynck, R., Sporn, M. B., & Fauci, A. S. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1037 · Cited by 1,582
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,482
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Signal Transduction by the TGF-β Superfamily
Attisano, L., & Wrana, J. L. (2002) · Science · doi:10.1126/science.1071809 · Cited by 1,268
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,151
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors
Goumans, M.-J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,123
Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S.-J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-189 · Cited by 1,116
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4
Nakao, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5353 · Cited by 1,070
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K.-I., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00690-6 · Cited by 1,028
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005912200 · Cited by 992
Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90193-0 · Cited by 975
Gorelik, L., & Flavell, R. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80170-3 · Cited by 962
Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Betaglycan presents ligand to the TGFβ signaling receptor
López-Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 901
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T.-T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 888
Defective Angiogenesis in Mice Lacking Endoglin
Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., & Wendel, D. P. (1999) · Science · doi:10.1126/science.284.5419.1534 · Cited by 852
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
Specificity, diversity, and regulation in TGF-beta superfamily signaling.
Piek, E., HELDIN, C., & ten Dijke, P. (1999) · PubMed · Cited by 783
Lothe, R. A., Peltomäki, P., Meling, G., Aaltonen, L. A., Nyström, M., Pylkkänen, L., Heimdal, K., Andersen, T. I., Møller, P., & Rognum, T. O. (1993) · PubMed · Cited by 778
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 724
Igarashi, A., Okochi, H., Bradham, D. M., & Grotendorst, G. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.6.637 · Cited by 706
Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689
Hocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675
Specificity, diversity, and regulation in TGF‐β superfamily signaling
PIEK, E., HELDIN, C., & DIJKE, P. T. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2105 · Cited by 656
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
Oshima, M., Oshima, H., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0259 · Cited by 645
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
Oft, M., Heider, K.-H., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 623
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., & Becker, K.-F. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64464-1 · Cited by 572
Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice
Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563
Masui, T., Wakefield, L. M., Lechner, J. F., LaVeck, M. A., Sporn, M. B., & Harris, C. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2438 · Cited by 562
Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 531
Bogdan, C., Paik, J., Vodovotz, Y., & Nathan, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50091-0 · Cited by 512
Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein
Stroschein, S. L., Wang, W., Zhou, S., Zhou, Q., & Luo, K. (1999) · Science · doi:10.1126/science.286.5440.771 · Cited by 492
Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer
Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H., & Cho, K. W. Y. (2000) · Nature · doi:10.1038/35001602 · Cited by 465
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-I., Shibuya, H., Matsumoto, K., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27161 · Cited by 442
Labbé, E., Letamendia, A., & Attisano, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150152697 · Cited by 440
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202642 · Cited by 436
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., & Dijke, P. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4557 · Cited by 426
Nucleocytoplasmic Shuttling of Smads 2, 3, and 4 Permits Sensing of TGF-β Receptor Activity
Inman, G. J., Nicolás, F. J., & Hill, C. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00585-3 · Cited by 417
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Mechanisms of TGF-β-mediated apoptosis
Schuster, N., & Krieglstein, K. (2002) · Cell and Tissue Research · doi:10.1007/s00441-001-0479-6 · Cited by 400
Frolik, C. A., Dart, L. L., Meyers, C. A., Smith, D. M., & Sporn, M. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3676 · Cited by 398
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis
Conery, A. R., Cao, Y., Thompson, E. A., Townsend, C. M., Ko, T. C., & Luo, K. (2004) · Nature Cell Biology · doi:10.1038/ncb1117 · Cited by 398
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., & Wakefield, L. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318899 · Cited by 393
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid, I., & Fontana, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3222 · Cited by 386
Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart
Brown, C. B., Boyer, A. S., Runyan, R. B., & Barnett, J. V. (1999) · Science · doi:10.1126/science.283.5410.2080 · Cited by 383
PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3
Remy, I., Montmarquette, A., & Michnick, S. W. (2004) · Nature Cell Biology · doi:10.1038/ncb1113 · Cited by 372
The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., & Hirai, H. (1998) · Nature · doi:10.1038/27945 · Cited by 371
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Lin, S.-Y., & Elledge, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00430-6 · Cited by 363
Andres, J. L., Stanley, K., Cheifetz, S., & Massagué, J. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.6.3137 · Cited by 354
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation
Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., & Weinberg, R. A. (2001) · Nature Cell Biology · doi:10.1038/35087019 · Cited by 349
Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I., & Arrick, B. A. (1992) · PubMed · Cited by 343
Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22044 · Cited by 337
Burrows, F. J., Derbyshire, E. J., Tazzari, P. L., Amlot, P. L., Gazdar, A. F., King, S. W., Letarte, M., Vitetta, E. S., & Thorpe, P. E. (1995) · PubMed · Cited by 334
Modulation of cytokine production by transforming growth factor-beta.
Chantry, D., Turner, M., Abney, E., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4295 · Cited by 323
Anscher, M. S., Peters, W. P., Reisenbichler, H., Petros, W. P., & Jirtle, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282203 · Cited by 316
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998) · Nature Medicine · doi:10.1038/nm0798-802 · Cited by 314
RNA interference: genetic wand and genetic watchdog
Bosher, J. M., & Labouesse, M. (2000) · Nature Cell Biology · doi:10.1038/35000102 · Cited by 313
Wikström, P., Stattin, P., Franck-Lissbrant, I., Damber, J.-E., & Bergh, A. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980915)37:1<19::aid-pros4>3.0.co;2-3 · Cited by 307
Endoglin modulates cellular responses to TGF-beta 1.
Lastres, P., Letamendía, A., Zhang, H., Rius, C., Almendro, N., Raab, U., López, L. A., Langa, C., Fabra, A., Letarte, M., et al. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.5.1109 · Cited by 304
TGFβ receptor internalization into EEA1-enriched early endosomes
Hayes, S., Chawla, A., & Corvera, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204088 · Cited by 301
Kaji, H., Canaff, L., Lebrun, J.-J., Goltzman, D., & Hendy, G. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061358098 · Cited by 300
Kurokowa, M., Lynch, K., & Podolsky, D. K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91481-1 · Cited by 297
Goggins, M., Shekher, M. C., Turnacioglu, K. K., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1998) · PubMed · Cited by 288
Systemic and local immunosuppression in pancreatic cancer patients.
von Bernstorff, W., Voss, M., Freichel, S., Schmid, A., Vogel, I., Jöhnk, C., Henne‐Bruns, D., Kremer, B., & Kalthoff, H. (2001) · PubMed · Cited by 279
McDonald, C. C., Alexander, F. E., Whyte, B. W., Forrest, A. P., & Stewart, H. J. (1995) · BMJ · doi:10.1136/bmj.311.7011.977 · Cited by 276
Tanaka, F., Otake, Y., Yanagihara, K., Kawano, Y., Miyahara, R., Li, M., Yamada, T., Hanaoka, N., Inui, K., & Wada, H. (2001) · PubMed · Cited by 274
Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling
Sun, Y., Liu, X., Eaton, E. N., Lane, W. S., Lodish, H. F., & Weinberg, R. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80201-4 · Cited by 263
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Kleeff, J., Ishiwata, T., Maruyama, H., Friess, H., Truong, P., Büchler, M. W., Falb, D., & Korc, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202909 · Cited by 258
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
Chen, W., Kirkbride, K. C., How, T., Nelson, C. D., Mo, J., Frederick, J. P., Wang, X.-F., Lefkowitz, R. J., & Blobe, G. C. (2003) · Science · doi:10.1126/science.1083195 · Cited by 258
Self-citationTGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα
Arsura, M., Wu, M., & Sonenshein, G. E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80307-6 · Cited by 250
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Reeves, R., Edberg, D. D., & Li, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.575-594.2001 · Cited by 242
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Sawyer, J. S., Anderson, B. D., Beight, D. W., Campbell, R. M., Jones, M. L., Herron, D. K., Lampe, J. W., McCowan, J. R., McMillen, W. T., Mort, N., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205705 · Cited by 236
Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, L., Roberts, A. B., Smith, G. H., & Merlino, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05832.x · Cited by 224
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223
Xie, W. Q., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., Haffty, B. G., & Reiß, M. (2002) · PubMed · Cited by 217
Shariat, S. F., Shalev, M., Menesses-Diaz, A., Kim, I. Y., Kattan, M. W., Wheeler, T. M., & Slawin, K. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2856 · Cited by 214
The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway
Hocevar, B. A., Smine, A., Xu, X., & Howe, P. H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2789 · Cited by 213
Activin receptor–like kinase 1 is implicated in the maturation phase of angiogenesis
Lamouille, S., Mallet, C., Feige, J.-J., & Bailly, S. (2002) · Blood · doi:10.1182/blood.v100.13.4495 · Cited by 211
TGF-β1 as an Enhancer of Fas-Mediated Apoptosis of Lung Epithelial Cells
Hagimoto, N., Kuwano, K., Inoshima, I., Yoshimi, M., Nakamura, N., Fujita, M., Maeyama, T., & Hara, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6470 · Cited by 207
Kong, F.-M., Anscher, M. S., Murase, T., Abbott, B. D., Iglehart, J. D., & Jirtle, R. L. (1995) · Annals of Surgery · doi:10.1097/00000658-199508000-00007 · Cited by 201
Epithelial Cell Plasticity in Development and Tumor Progression
Thiery, J. P., & Chopin, D. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006256219004 · Cited by 197
Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells
Villanueva, A., García, C., Paules, A. B., Vicente, M., Megías, M., Reyes, G., de Villalonga, P., Agell, N., Lluís, F., Bachs, O., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202118 · Cited by 194
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 188
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Regulation of Smad signaling by protein kinase C
Yakymovych, I., Dijke, P. T., Heldin, C., & Souchelnytskyi, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0474fje · Cited by 180
Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer
Ivanovic, V., Melman, A., Davis-Joseph, B., Valcic, M., & Geliebter, J. (1995) · Nature Medicine · doi:10.1038/nm0495-282 · Cited by 176
Penheiter, S. G., Mitchell, H., Garamszegi, N., Edens, M., Doré, J. J. E., & Leof, E. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4750-4759.2002 · Cited by 167
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.
Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., & Peeper, D. S. (1995) · Genes & Development · doi:10.1101/gad.9.2.204 · Cited by 166
Context-specific Effects of Fibulin-5 (DANCE/EVEC) on Cell Proliferation, Motility, and Invasion
Schiemann, W. P., Blobe, G. C., Kalume, D. E., Pandey, A., & Lodish, H. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200148200 · Cited by 164
Self-citationAtfi, A., Buisine, M., Mazars, A., & Gespach, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24731 · Cited by 162
Axin Facilitates Smad3 Activation in the Transforming Growth Factor β Signaling Pathway
Furuhashi, M., Yagi, K., Yamamoto, H., Furukawa, Y., Shimada, S., Nakamura, Y., Kikuchi, A., Miyazono, K., & Kato, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5132-5141.2001 · Cited by 162
Dumont, N., Bakin, A. V., & Arteaga, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204623200 · Cited by 159
Transforming Growth Factor-β1 Triggers Hepatocellular Carcinoma Invasiveness via α3β1 Integrin
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S. C., Schiraldi, O., & Antonaci, S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64170-3 · Cited by 158
The MEK Pathway Is Required for Stimulation of p21WAF1/CIP1 by Transforming Growth Factor-β
Hu, P. P.-C., Shen, X., Huang, D., Liu, Y. I., Counter, C. M., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35381 · Cited by 157
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 156
Betaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex Formation
Eickelberg, O., Reiß, M., Kashgarian, M. J., & Wells, R. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105110200 · Cited by 149
Tsushima, H., Ito, N., Tamura, S., Matsuda, Y., Inada, M., Yabuuchi, I., Imai, Y., Nagashima, R., Misawa, H., Takeda, H., et al. (2001) · PubMed · Cited by 149
Karumanchi, S. A., Knebelmann, B., Grüning, W., Dhanabal, M., Walz, G., Stillman, I. E., & Sukhatme, V. P. (1999) · PubMed · Cited by 147
Invasion and metastasis of a mammary tumor involves TGF-? signaling
McEarchern, J. A., Kobie, J. J., Mack, V. E., Wu, R. S., Meade‐Tollin, L. C., Arteaga, C. L., Dumont, N., Besselsen, D. G., Seftor, E. A., Hendrix, M. J. C., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<76::aid-ijc1012>3.0.co;2-8 · Cited by 147
Matsuno, F., Haruta, Y., Kondo, M., Tsai, H., Barcos, M. P., & Seon, B. K. (1999) · PubMed · Cited by 144
Nicolás, F. J., & Hill, C. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206420 · Cited by 144
Hoosein, N. M., McKnight, M. K., Levine, A. E., Mulder, K. M., Childress‐Fields, K. E., Brattain, D. E., & Brattain, M. G. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90101-8 · Cited by 143
Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.
Ewan, K., Henshall-Powell, R. L., Ravani, S. A., Pajares, M. J., Arteaga, C. L., Warters, R., Akhurst, R. J., & Barcellos‐Hoff, M. H. (2002) · PubMed · Cited by 142
Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death
Krieglstein, K., Richter, S., Farkas, L. M., et al. (2000) · Nature Neuroscience · doi:10.1038/80598 · Cited by 141
Blobe, G. C., Schiemann, W. P., Pépin, M.-C., Beauchemin, M., Moustakas, A., Lodish, H. F., & O'Connor‐McCourt, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100188200 · Cited by 140
Self-citationKnaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., & Lodish, H. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3480 · Cited by 140
Krasagakis, K., Thölke, D., Farthmann, B., Eberle, J., Mansmann, U., & Orfanos, C. E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.245 · Cited by 138
Shim, K. S., Kim, K. H., Han, W. S., & Park, E. B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<554::aid-cncr6>3.0.co;2-x · Cited by 138
Kong, F., Jirtle, R. L., Huang, D. H., Clough, R. W., & Anscher, M. S. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991101)86:9<1712::aid-cncr12>3.0.co;2-v · Cited by 135
Fonsatti, E., Jekunen, A. P., Kairemo, K., et al. (2000) · PubMed · Cited by 135
Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells
Landström, M., Heldin, N., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., & Heldin, C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00470-x · Cited by 133
Stampfer, M. R., Garbe, J. C., Levine, G. A., Lichtsteiner, S., Vasserot, A. P., & Yaswen, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071483998 · Cited by 131
Kanamoto, T., Hellman, U., Heldin, C., & Souchelnytskyi, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1219 · Cited by 130
Alexandrow, M. G., Kawabata, M., Aakre, M. E., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3239 · Cited by 130
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
MacGrogan, D., Pegram, M. D., Slamon, D. J., & Bookstein, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201232 · Cited by 125
Transforming growth factor‐β1 as a useful serologic marker of small hepatocellular carcinoma
Song, B., Chung, Y., Kim, J. A., Choi, W.-B., Suh, D. D., Pyo, S. I., Shin, J. W., Lee, H. C., Lee, Y. S., & Suh, D. J. (2001) · Cancer · doi:10.1002/cncr.10170 · Cited by 120
Li, C., Gardy, R., Seon, B. K., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600874 · Cited by 120
Ständer, M., Naumann, U., Dumitrescu, L., Heneka, M. T., Löschmann, P.-A., Gulbins, E., DICHGANS, J., & Weller, M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300709 · Cited by 119
Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells
Katakura, Y., Nakata, E., Miura, T., & Shirahata, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0129 · Cited by 117
Hsing, A. Y., Kadomatsu, K., Bonham, M. J. D., & Danielpour, D. (1996) · PubMed · Cited by 115
Kim, I. Y., Ahn, H. J., Lang, S., Oefelein, M. G., Oyasu, R., Kozlowski, J. M., & Lee, C. (1998) · PubMed · Cited by 114
TGF-β expression in the human colon: differential immunostaining along crypt epithelium
Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M. B., & Moorghen, M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.301 · Cited by 110
Park, B.-J., Park, J., Byun, D.-S., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 109
Kim, B.-C., Mamura, M., Choi, K. S., Calabretta, B., & Kim, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1369-1378.2002 · Cited by 107
Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells
Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman‐Roman, S., Cherqui, G., & Atfi, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204167 · Cited by 106
Lafon, C., Mathieu, C., Guerrin, M., Pierre, O., Vidal, S., & Valette, A. (1996) · PubMed · Cited by 102
Copland, J. A., Luxon, B. A., Ajani, L., Maity, T., Campagnaro, E. L., Guo, H., LeGrand, S. N., Tamboli, P., & Wood, C. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206835 · Cited by 101
Picon, A. I., Gold, L. I., Wang, J., Cohen, A. M., & Friedman, E. D. (1998) · PubMed · Cited by 100
Datto, M., Hu, P. P.-C., Kowalik, T. F., Yingling, J. M., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2030 · Cited by 99
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (2000) · PubMed · Cited by 91
Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
Ghellal, A., Li, C., Hayes, M., Byrne, G. J., Bundred, N. J., & Kumar, S. (2000) · PubMed · Cited by 90
Inman, G. J., & Allday, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2500 · Cited by 90
Arsura, M., Fitzgerald, M. J., Fausto, N., & Sonenshein, G. E. (1997) · PubMed · Cited by 90
Feng, P., Catt, K. J., & Knecht, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66998-4 · Cited by 89
Ishikawa, O., LeRoy, E. C., & Trojanowska, M. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450124 · Cited by 86
Danielpour, D. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.2.169 · Cited by 84
Osada, H., Tatematsu, Y., Masuda, A., Saito, T., Sugiyama, M., Yanagisawa, K., & Takahashi, T. (2001) · PubMed · Cited by 83
Park, S. H., Lee, S. R., Kim, B. C., Cho, E. A., Patel, S. P., Kang, H., Sausville, E. A., Nakanishi, O., Trepel, J. B., Lee, B. I., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106451200 · Cited by 80
Boulay, J.-L., Mild, G., Lowy, A. J., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600511 · Cited by 79
CD105 Expression Is a Marker of High Metastatic Risk and Poor Outcome in Breast Carcinomas
Lavaut, M. M.-N., Garcia, S., Duffaud, F., Allasia, C., Bonnier, P., Andrac, L., Charpin, M. C., Dales, M. J.-P., & Ramuz, O. (2003) · American Journal of Clinical Pathology · doi:10.1309/1kf54l6rb625556w · Cited by 78
Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells
Lei, X., Bandyopadhyay, A. M., Le, T., & Sun, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205966 · Cited by 77
Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes‐Davies, L., Kemp, P. R., & Hesketh, R. (2001) · PubMed · Cited by 76
Protein kinase C βII and TGFβRII in ω-3 fatty acid–mediated inhibition of colon carcinogenesis
Murray, N. R., Weems, C. R., Chen, L., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201127 · Cited by 72
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink, S. P., Swinler, S. E., Lutterbaugh, J., Massagué, J., Thiagalingam, S., Kinzler, K. W., Vogelstein, B., Willson, J. K. V., & Markowitz, S. D. (2001) · PubMed · Cited by 71
Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli.
Brandes, M. E., Wakefield, L. M., & Wahl, S. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55048-1 · Cited by 70
Glick, A. B., Popescu, N. C., Alexander, V., Ueno, H., Böttinger, E. P., & Yuspa, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14949 · Cited by 65
Kim, W. S., Park, C., Jung, Y. S., Kim, H. S., Han, J., Park, C. H., Kim, K., Kim, J., Shim, Y. M., & Park, K. (1999) · PubMed · Cited by 64
Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas
Jonson, T., Albrechtsson, E., Axelson, J., et al. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.1.71 · Cited by 63
Wojtowicz‐Praga, S., Verma, U. M., Wakefield, L. M., López-Jamar, J. M. E., Hartmann, D., & Mazumder, A. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199605000-00001 · Cited by 60
Hyman, K. M., Seghezzi, G., Pintucci, G., Stellari, G. M., Kim, J. H., Grossi, E. A., Galloway, A. C., & Mignatti, P. (2002) · Surgery · doi:10.1067/msy.2002.125304 · Cited by 60
de Jonge, R. R., Garrigue‐Antar, L., Vellucci, V. F., & Reiss, M. (1997) · PubMed · Cited by 58
Tobin, S. W., Douville, K. L., Benbow, U., Brinckerhoff, C., Memoli, V. A., & Arrick, B. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205026 · Cited by 58
Involvement of p38 MAP kinase in TGF‐β‐stimulated VEGF synthesis in aortic smooth muscle cells
Yamamoto, T., Kozawa, O., Tanabe, K., Akamatsu, S., Matsuno, H., Dohi, S., & Uematsu, T. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1179 · Cited by 55
Tsai, J.-F., Jeng, J., Chuang, L.-Y., Yang, M., Ho, M., Chang, W., Hsieh, M., Lin, Z., & Tsai, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.369 · Cited by 52
Down-regulation of TGF-β 1 production restores immunogenicity in prostate cancer cells
Matthews, E. K., Yang, T., Janulis, L., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1257 · Cited by 46
Werner, S., Beer, H., Mauch, C., Lüscher, B., & Werner, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204937 · Cited by 46
Future prospects in prostate cancer
Hegarty, N. J., Fitzpatrick, J. M., Richie, J. P., Scardino, P. T., White, R. D., Schr�der, F. H., & Coffey, D. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990901)40:4<225::aid-pros3>3.0.co;2-3 · Cited by 45
TGFβ1 induces a cell-cycle-dependent increase in motility of epithelial cells
Zicha, D., Genot, E. M., Dunn, G., & Kramer, I. M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.4.447 · Cited by 42
Increased TGFβ1 plasma level in patients with lung cancer: potential mechanisms
Barthelemy-Brichant, N., David, J., Bosquée, L., Bury, T., Seidel, L., Albert, A., Bartsch, P., Baugnet-Mahieu, L., & Deneufbourg, J.-M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00956.x · Cited by 40
Yan, Z., Deng, X., & Friedman, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004553200 · Cited by 39
Impediments to Successful Immunotherapy
Hersey, P. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00038-2 · Cited by 38
Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy
Kirkbride, K. C., & Blobe, G. C. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.251 · Cited by 37
Self-citationAdnane, J., Bizouarn, F. A., Chen, Z., Ohkanda, J., Hamilton, A. D., Muñoz-Antonia, T., & Sebti, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203920 · Cited by 29
Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes
Cullingworth, J., Hooper, M., Harrison, D. J., Mason, J. O., Sirard, C., Patek, C. E., & Clarke, A. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205673 · Cited by 26
Miyajima, A., Asano, T., & Hayakawa, M. (2001) · The Journal of Urology · doi:10.1097/00005392-200102000-00083 · Cited by 23
Cited by
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Self-citationTumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582
Metadata
- Authors
- Elliott, R. L., & Blobe, G. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-03-20
- Volume
- 23
- Issue
- 9
- Pages
- 2078-2093
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2147754310
- Cited by
- 709
- References
- 203
- FWCI
- 21.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.